We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14B
AUM Growth
+$1.55B
(+12%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
266
New
32
Increased
101
Reduced
90
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$114M |
| 2 |
Novartis
NVS
|
+$98.3M |
| 3 |
Carter's
CRI
|
+$80.1M |
| 4 |
Brixmor Property Group
BRX
|
+$77.5M |
| 5 |
Citigroup
C
|
+$75.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$340M |
| 2 |
Adobe
ADBE
|
+$106M |
| 3 |
Marriott International
MAR
|
+$99.8M |
| 4 |
Cisco
CSCO
|
+$81.3M |
| 5 |
Progressive
PGR
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.58% |
| 2 | Healthcare | 17.58% |
| 3 | Industrials | 13.74% |
| 4 | Financials | 11.64% |
| 5 | Consumer Discretionary | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caesars Entertainment
CZR
$6.14B
| $134M | 0.96% |
2,249,305
+888,446
| +65% | +$44M |
|
27
DexCom
DXCM
$32.8B
| $134M | 0.95% |
2,448,496
+122,684
| +5% | +$5.82M |
|
28
Charter Communications
CHTR
$18.3B
| $129M | 0.92% |
265,860
-92,747
| -26% | -$42.7M |
|
29
Boston Scientific
BSX
$71.1B
| $118M | 0.84% |
2,618,634
+647,200
| +33% | +$27.1M |
|
30
Illinois Tool Works
ITW
$84.9B
| $117M | 0.84% |
653,954
-133,067
| -17% | -$22.5M |
|
31
Icon
ICLR
$12.1B
| $117M | 0.83% |
679,761
+22,615
| +3% | +$3.49M |
|
32
Caterpillar
CAT
$404B
| $116M | 0.83% |
788,043
+47,037
| +6% | +$6.56M |
|
|
MDCO
33
DELISTED
Medicines Co
MDCO
| $116M | 0.83% |
1,368,720
-5,099,682
| -79% | -$340M |
|
34
LPL Financial
LPLA
$27.9B
| $115M | 0.82% |
1,251,728
+367,788
| +42% | +$31.6M |
|
35
TransUnion
TRU
$15.7B
| $115M | 0.82% |
1,346,729
+71,856
| +6% | +$5.98M |
|
36
Blackstone
BX
$110B
| $112M | 0.8% |
2,004,520
+241,409
| +14% | +$12.5M |
|
37
Fortinet
FTNT
$123B
| $112M | 0.8% |
5,245,105
+245,160
| +5% | +$4.61M |
|
38
Arthur J. Gallagher & Co
AJG
$63.6B
| $112M | 0.8% |
1,174,661
+52,076
| +5% | +$4.77M |
|
39
Broadcom
AVGO
$1.99T
| $111M | 0.79% |
3,523,480
+50,280
| +1% | +$1.53M |
|
40
Brookfield
BN
$109B
| $108M | 0.77% |
5,246,489
-426,511
| -8% | -$8.5M |
|
41
Steris
STE
$22.7B
| $108M | 0.77% |
706,691
+7,698
| +1% | +$1.13M |
|
42
Union Pacific
UNP
$176B
| $104M | 0.74% |
577,834
+34,997
| +6% | +$5.99M |
|
|
43
Novartis
NVS
$291B
| $104M | 0.74% |
+1,095,518
| New | +$98.3M |
|
44
JB Hunt Transport Services
JBHT
$25.8B
| $104M | 0.74% |
887,374
+43,372
| +5% | +$4.98M |
|
45
Alexandria Real Estate Equities
ARE
$8.52B
| $102M | 0.73% |
631,843
-2,792
| -0.4% | -$440K |
|
46
Bristol-Myers Squibb
BMY
$135B
| $97.4M | 0.69% |
1,517,630
-157,223
| -9% | -$9M |
|
47
NCR Voyix
VYX
$1.22B
| $96.8M | 0.69% |
4,488,053
+2,283,121
| +104% | +$44.4M |
|
48
Nice
NICE
$6.05B
| $91.5M | 0.65% |
589,500
+21,417
| +4% | +$3.27M |
|
49
Hilton Worldwide
HLT
$70.2B
| $91.3M | 0.65% |
823,135
+52,567
| +7% | +$5.27M |
|
50
Constellation Brands
STZ
$22.4B
| $90.1M | 0.64% |
474,801
-27,155
| -5% | -$5.13M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Westfield Capital Management held 266 positions worth $14B, up 12% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Westfield Capital Management's Q4 2019 filing shows 32 new, 101 increased, 90 reduced and 35 closed positions. Its largest new stake was Novartis: 1,095,518 shares worth $104M. The largest sale was Medicines Co, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2019 buy was Novartis: 1,095,518 shares worth $104M.
- Westfield Capital Management added most to TransDigm Group in Q4 2019, an estimated $114M increase.
- Westfield Capital Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $340M.
- Westfield Capital Management fully exited Adobe in Q4 2019, selling an estimated $106M.
- Westfield Capital Management's ten largest holdings make up 20% of its $14B portfolio in Q4 2019.
- Westfield Capital Management opened 32 new positions and closed 35 in Q4 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $14B.
Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.